Mechanism of Action: Herceptin (Trastuzumab)

Article

The mechanism of action of trastuzumab (Herceptin), a monoclonal antibody that is approved for the treatment of early-stage breast cancer that is HER2-positive.

Tweet

Trastuzumab (Herceptin) is a monoclonal antibody that interferes with the HER2/neu receptor. Herceptin is approved for the treatment of early-stage breast cancer that isHumanEpidermal growth factorReceptor2

Recent Videos
Related Content
Adjuvant T-DM1 Outperforms Trastuzumab in HER2-Positive Early Breast Cancer

Adjuvant T-DM1 Outperforms Trastuzumab in HER2-Positive Early Breast Cancer

Brielle Benyon
February 12th 2025
Article

Ado-trastuzumab emtansine led to improved overall survival and invasive disease–free survival over trastuzumab in patients with HER2-positive early breast cancer who had residual invasive disease after neoadjuvant therapy.

Read More

Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia

Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia

Jordyn Sava;Aditya Bardia, MD, MPH
February 6th 2025
Podcast

In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan in breast cancer.

Listen

FDA Considers BLA for Pertuzumab Biosimilar HLX11 in Breast Cancer

FDA Considers BLA for Pertuzumab Biosimilar HLX11 in Breast Cancer

Jordyn Sava
February 5th 2025
Article

FDA reviews biologics license application for HLX11, a biosimilar to pertuzumab, for HER2-positive breast cancer.

Read More

Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

Jordyn Sava;Sanjay K. Juneja, MD
January 15th 2025
Podcast

In this episode of Targeted Talks, Sanjay K. Juneja, MD, discusses the exciting advancements of artificial intelligence in 2024.

Listen

New Insights into the Links Between Heart Disease and Breast Cancer

New Insights into the Links Between Heart Disease and Breast Cancer

Amy M. Ahnert, MD
February 3rd 2025
Article

For Heart Health Month, Amy Ahnert, MD, Director, Women’s Heart Program at Morristown Medical Center, Atlantic Health System, discussed the link between cardiovascular disease and breast cancer.

Read More

A Real-Time Cancer-Detecting System for Breast Cancer Goes Live

A Real-Time Cancer-Detecting System for Breast Cancer Goes Live

Morgan Bayer
January 30th 2025
Article

The LumiSystem detection tool is now commercially available in the US.

Read More